Spots Global Cancer Trial Database for stomach neoplasms
Every month we try and update this database with for stomach neoplasms cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Exploratory Study of Drug Sensitivity Prediction Software (IRCR-DReSS) With Patient-derived Tumor Cells of Metastatic Gastric Cancer | NCT03170180 | Stomach Neoplas... | Sunitinib Gefitinib Imatinib | 20 Years - | Samsung Medical Center | |
The Role of Artificial Intelligence in Endoscopic Diagnosis of Esophagogastric Junctional Adenocarcinoma:A Single Center, Case-control, Diagnostic Study | NCT05819099 | Stomach Neoplas... | An Intelligent ... | 18 Years - 75 Years | Qilu Hospital of Shandong University | |
Study Evaluating the Efficacy and Safety With CAR-T for Stomach Cancer | NCT02725125 | Stomach Neoplas... | EPCAM-targeted ... | - 75 Years | Sinobioway Cell Therapy Co., Ltd. | |
Narrow Band Imaging for Gastric Neoplasia | NCT02197351 | Gastric Cancer Gastric Metapla... Gastric Dysplas... | White light bio... Protocolled Narrow Band Ima... | 18 Years - | University of Southern California | |
A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors | NCT06131840 | Colorectal Neop... Carcinoma, Non-... Stomach Neoplas... Pancreatic Duct... Gastroesophagea... Small Cell Lung... | SGN-CEACAM5C | 18 Years - | Seagen Inc. | |
PD-1 Blockade With JS001 Plus Neoadjuvant Chemotherapy for Gastric/Gastroesophageal Junction Cancer | NCT05033392 | Stomach Neoplas... | Toripalimab Inj... | 18 Years - 79 Years | Shenzhen People's Hospital | |
Intravenous Edotecarin in Patients With Advanced Gastric Cancer That Has Progressed or Recurred After Chemotherapy | NCT00087503 | Stomach Neoplas... | Edotecarin | 18 Years - | Pfizer | |
Taxotere New Indication - Gastric Cancer Treatment Registration Trial | NCT00811447 | Stomach Neoplas... | 5-fluorouracil Cisplatin Docetaxel | 18 Years - 70 Years | Sanofi | |
CAR-macrophages for the Treatment of HER2 Overexpressing Solid Tumors | NCT04660929 | HER2-positive Adenocarcinoma Bile Duct Cance... Biliary Tract C... Bladder Cancer Breast Cancer Breast Neoplasm Carcinoma, Duct... Carcinoma, Hepa... Cancer Lung Cancer, No... Carcinoma, Ovar... Carcinoma, Smal... Carcinoma, Squa... Carcinoma, Tran... Colorectal Canc... Esophagogastric... Inflammatory Br... Stomach Neoplas... Malignant Neopl... Ovarian Neoplas... Pancreatic Canc... HER2-positive S... HER2-positive B... HER2-positive G... HER-2 Protein O... HER-2 Gene Ampl... Prostate Cancer Head and Neck C... Endometrial Can... Lung Cancer, Sm... | CT-0508 Pembrolizumab | 18 Years - | Carisma Therapeutics Inc | |
Study of Oxaliplatin, Calcium Folinate, and 5-Fluorouracil as Neoadjuvant Chemotherapy for Resectable Advanced Gastric Cancer | NCT00591045 | Stomach Neoplas... Gastric Cancer | mFOLFOX | 30 Years - 70 Years | Peking University | |
Multicenter Study on Laparoscopic Distal Subtotal Gastrectomy for Advanced Gastric Cancer (CLASS-01) | NCT01609309 | Stomach Neoplas... | Laparoscopic ga... Open gastrectom... | 19 Years - 74 Years | Nanfang Hospital, Southern Medical University | |
Comparation of Endoscopic Biopsy and Postoperative Specimen for the Molecular Diagnosis of Gastric Cancer | NCT04809025 | Stomach Neoplas... Endoscopy Biopsy Pathology | endoscopy Surgery | 18 Years - 75 Years | Fudan University | |
Effectiveness of Managing Suspected Metastasis and Progress Using Plasma D-dimer Testing in Gastric Cancer Patients | NCT04953585 | Stomach Neoplas... | radical gastrec... | 18 Years - | First Affiliated Hospital Xi'an Jiaotong University | |
Helicobacter Pylori Eradication to Prevent Gastric Cancer | NCT01133951 | Helicobacter In... Stomach Neoplas... | OAC triple ther... Placebo | 30 Years - 59 Years | Second Military Medical University | |
Prospective Study on Modified Delta-shaped Gastroduodenostomy in Totally Laparoscopic Surgery for Distal Gastric Cancer | NCT02289183 | Stomach Neoplas... | Totally laparos... Laparoscopy-ass... | 18 Years - 75 Years | Fujian Medical University | |
Biweekly Docetaxel in Combination With Capecitabine as First-Line Treatment in Patients With Advanced Gastric Cancer | NCT00669370 | Stomach Neoplas... | docetaxel and c... | 18 Years - | University of Turku | |
Influence of Positive Margins on Tumour Recurrence and Overall Survival After Gastrectomy for Gastric Cancer | NCT04439812 | Stomach Neoplas... | Observation | - | Hospital Universitario Ramon y Cajal | |
Trastuzumab Plus Docetaxel and Capecitabine For First Line Treatment of Her2-Positive Advanced Gastric Cancer | NCT02004769 | Stomach Neoplas... Neoplasms Metas... ERBB2 Gene Ampl... | Trastuzumab Docetaxel Capecitabine | 18 Years - 75 Years | Sun Yat-sen University | |
Docetaxel in Locally Advanced Gastric Adenocarcinoma | NCT00343239 | Stomach Neoplas... | Docetaxel Cisplatin Fluorouracil | 18 Years - 70 Years | Sanofi | |
Pulsed Low Dose Rate Radiation Therapy for Gastric Cancer Patients With Peritoneal Metastasis | NCT03061162 | Radiotherapy Radiotherapy Si... Stomach Neoplas... | pulsed low dose... | 18 Years - | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | |
Feasibility and Safety of Robotic Assisted Proximal Gastrectomy With Double-flap Technique for Proximal Early Gastric Cancer | NCT05892289 | Stomach Neoplas... | Robotic assiste... | 20 Years - 80 Years | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | |
Cytoreductive Surgery Combined With HIPEC and Chemotherapy for Gastric Cancer With Peritoneal Metastasis | NCT03023436 | Stomach Neoplas... | Cytoreductive s... Hyperthermic In... Fluoropyrimidin... Cisplatin | 19 Years - 74 Years | Nanfang Hospital, Southern Medical University | |
Immunohistochemical & Immunoblot Analysis of NIS (Na+/I-Symporter) in Archival & Frozen Tissue Sample | NCT00568438 | Breast Cancer Stomach Neoplas... Salivary Gland ... Thyroid Cancer | 18 Years - | Stanford University | ||
Acupuncture for QoL and Symptoms in Gastric Cancer During Adjuvant Chemotherapy | NCT04360577 | Stomach Neoplas... | acupuncture | 18 Years - 75 Years | Guangzhou University of Traditional Chinese Medicine | |
An International Phase 2 Study Of SU011248 In Patients With Advanced / Metastatic Gastric Cancer Failing Chemotherapy | NCT00226811 | Stomach Neoplas... | Sunitinib | 18 Years - | Pfizer | |
Feasibility and Safety of Robotic Assisted Proximal Gastrectomy With Double-flap Technique for Proximal Early Gastric Cancer | NCT05892289 | Stomach Neoplas... | Robotic assiste... | 20 Years - 80 Years | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | |
Trial of Docetaxel, Oxaliplatin and Capecitabine (TEX) in Advanced or Metastatic Gastric Cancer | NCT00511446 | Stomach Neoplas... | docetaxel, oxal... | 18 Years - | Martin-Luther-Universität Halle-Wittenberg | |
An Evaluation of the Utility of the ExSpiron Respiratory Variation Monitor During Upper GI Endoscopy | NCT02310230 | Biliary Tract D... Stomach Neoplas... Carcinoma, Panc... Barrett Esophag... | ExSpiron Respir... | 21 Years - | University of Vermont | |
Comparison of the Efficiency Between Intraoperative and Postoperative Hyperthermic Intraperitoneal Chemotherapy With Docetaxel Combine Oxaliplatin in Patients With Advanced Gastric Cancer | NCT04522011 | Stomach Neoplas... Hyperthermic In... | intraoperative ... | 18 Years - 65 Years | First Affiliated Hospital Xi'an Jiaotong University | |
Trial of Single Agent AZD2014 in RICTOR Amplified GC Patients as Second-line Therapy | NCT03061708 | Stomach Neoplas... | AZD2014 | 18 Years - | Samsung Medical Center | |
Intraperitoneal Paclitaxel With XELOX in Gastric Cancer With Peritoneal Metastasis | NCT04943653 | Stomach Neoplas... Paclitaxel Peritoneal Meta... | Paclitaxel | 20 Years - 80 Years | Seoul St. Mary's Hospital | |
The Effect of Satiety Gut Hormone Modulation on Appetitive Drive After Upper Gastrointestinal Surgery | NCT02381249 | Esophageal Neop... Stomach Neoplas... Weight Loss Malnutrition Pancreatic Neop... Duodenal Neopla... | Octreotide Placebo | 18 Years - 100 Years | St. James's Hospital, Ireland | |
Tissue Procurement and Natural History Study of Patients With Malignant Mesothelioma | NCT01950572 | Mesothelioma Thymoma Pancreatic Neop... Biliary Tract N... Stomach Neoplas... | 2 Years - | National Institutes of Health Clinical Center (CC) | ||
Cisplatin and S-1 With or Without Nimotuzumab in Untreated Advanced Gastric Adenocarcinoma | NCT02370849 | Stomach Neoplas... | nimotuzumab cisplatin S-1 | 18 Years - | ChineseAMS | |
Trial of Single Agent AZD2014 in RICTOR Amplified GC Patients as Second-line Therapy | NCT03061708 | Stomach Neoplas... | AZD2014 | 18 Years - | Samsung Medical Center | |
OLGA and OLGIM Stage System for Gastric Cancer | NCT03380052 | Stomach Neoplas... Atrophic Gastri... Intestinal Meta... | 25 Years - 80 Years | Seoul National University Bundang Hospital | ||
A Clinical Trial of Two Adjuvant Chemotherapy Regimens for Postoperative Gastric Cancer | NCT04351867 | Stomach Neoplas... | docetaxel plus ... oxaliplatin plu... | 18 Years - 75 Years | Henan Cancer Hospital | |
Postoperative Analgesic Effect of Nefopam | NCT02561494 | Stomach Neoplas... | Nefopam Saline | 20 Years - 70 Years | Seoul National University Bundang Hospital | |
Tissue Procurement and Natural History Study of Patients With Malignant Mesothelioma | NCT01950572 | Mesothelioma Thymoma Pancreatic Neop... Biliary Tract N... Stomach Neoplas... | 2 Years - | National Institutes of Health Clinical Center (CC) | ||
A Study of Intraperitoneal Paclitaxel in Combination With SOX Compared With SOX Alone in Gastric Cancer With Malignant Ascites | NCT03475615 | Gastric Cancer Stomach Neoplas... | Oxaliplatin Paclitaxel S-1 (Tegafur, G... | 18 Years - | Fudan University | |
Development and Testing of a Social Cognitive Theory-based Dietary Behavioral Intervention in Gastric Cancer Survivors | NCT04985084 | Stomach Neoplas... Cancer Survivor... | The interventio... Usual care | 18 Years - 75 Years | The Hong Kong Polytechnic University | |
Docetaxel and Epirubicin in Advanced Gastric Cancer | NCT00375999 | Stomach Neoplas... | Docetaxel and e... | 18 Years - | Yonsei University | |
Neoadjuvant Chemotherapy With SEEOX Regimen for Borrmann Type 4 Gastric Cancer | NCT02949258 | Stomach Neoplas... Gastric Cancer | oxaliplatin etoposide epirubicin S1 | 30 Years - 75 Years | Jinling Hospital, China | |
A Study of Amivantamab in Participants With Previously Treated Advanced or Metastatic Gastric or Esophageal Cancer | NCT04945733 | Stomach Neoplas... Esophageal Neop... | Amivantamab | 20 Years - | Janssen Pharmaceutical K.K. | |
ctDNA for Prediction of Relapse in Gastric Cancer | NCT02887612 | Stomach Neoplas... | ctDNA test | 18 Years - 80 Years | Sun Yat-sen University | |
Fruquintinib Combined With Sintilimab as Second-line Therapy for Gastric or Gastro-esophageal Junction Adenocarcinoma | NCT05625737 | Stomach Neoplas... | Fruquintinib Sintilimab | 18 Years - 75 Years | Wuhan Union Hospital, China | |
Trials Comparing of HD Versus 4K Laparoscopy for Gastric Cancer | NCT04010006 | Stomach Neoplas... | 4K Laparoscopic... HD Laparoscopic... | 19 Years - 74 Years | Fujian Medical University | |
Indocyanine Green Tracer Using in Laparoscopic Distal Gastrectomy for Early Gastric Cancer | NCT04973475 | Early Gastric C... Indocyanine Gre... Lymph Node Diss... | Indocyanine Gre... | 18 Years - 75 Years | Fujian Medical University | |
Second Line Chemotherapy for S-1 Refractory Advanced Gastric Cancer | NCT00639327 | Gastric Cancer | S-1 + irinoteca... irinotecan | 20 Years - | Japan Clinical Cancer Research Organization | |
Combination Chemotherapy in Treating Patients With Advanced Stomach, Gastroesophageal, or Esophageal Cancer | NCT01928290 | Stomach Neoplas... Esophageal Neop... | Irinotecan Trastuzumab Oxaliplatin Leucovorin Fluorouracil | 18 Years - | Washington University School of Medicine | |
Phase I Trial of Afatinib and Trastuzumab in HER2 Overexpressing Cancer. | NCT01649271 | Breast Neoplasm... Stomach Neoplas... | Herceptin afatinib trastuzumab Herceptin afatinib afatinib | 18 Years - 99 Years | Boehringer Ingelheim | |
Efficacy Study of a Low Volume of Water Intake and Mosapride for Endoscopy in Patients With Subtotal Gastrectomy | NCT01284764 | Foreign Body Le... | Mosapride | 18 Years - 80 Years | Inje University | |
A Study to Explore the Efficacy and Safety of Atezolizumab Plus Tiragolumab and Chemotherapy in 1st Line HER2 Negative Unresectable, Recurrent or Metastatic Gastric Cancer or Adenocarcinoma of Gastroesophageal Junction (GEJ) | NCT04933227 | Stomach Neoplas... Gastric Cancer Gastroesophagea... | Atezolizumab Tiragolumab Oxaliplatin Capecitabine | 18 Years - | Hoffmann-La Roche | |
Laparoscopic Proximal Gastrectomy With Double-flap Technique Versus Laparoscopic Total Gastrectomy With Roux-en-Y Reconstruction for Proximal Early Gastric Cancer | NCT05890339 | Stomach Neoplas... | Laparoscopic Pr... Laparoscopic To... | 20 Years - 80 Years | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | |
Postoperative Analgesic Effect of Subcostal TAPB for Laparoscopic Gastrectomy | NCT04138901 | Postoperative P... | Ultrasound guid... Ropivacaine 0.7... 21G 100 mm stim... | 18 Years - 80 Years | Seoul National University Hospital | |
Premedication With Simethicone or Simethicone Plus N-acetylcysteine in Improving Visibility During Upper Endoscopy | NCT01653171 | Stomach Neoplas... | Water (Placebo) Simethicone N-acetylcystein... N-acetylcystein... | 18 Years - | Pontificia Universidad Catolica de Chile | |
A Study of SGN-STNV in Advanced Solid Tumors | NCT04665921 | Carcinoma, Non-... HER2 Negative B... Ovarian Neoplas... Uterine Cervica... Endometrial Neo... Esophageal Neop... Gastroesophagea... Stomach Neoplas... Colorectal Neop... Exocrine Pancre... Appendiceal Ade... Pseudomyxoma Pe... | SGN-STNV | 18 Years - | Seagen Inc. | |
Compliance to ERAS After Gastric Surgery | NCT01653496 | Stomach Neoplas... | Enhanced recove... | 18 Years - 70 Years | Chonnam National University Hospital | |
Indocyanine Green Tracer Using in Laparoscopic Distal Gastrectomy for Early Gastric Cancer | NCT04973475 | Early Gastric C... Indocyanine Gre... Lymph Node Diss... | Indocyanine Gre... | 18 Years - 75 Years | Fujian Medical University | |
Study on Laparoscopic Spleen-Preserving No. 10 Lymph Node Dissection for Advanced Gastric Cancer | NCT02845986 | Stomach Neoplas... | Laparoscopic Sp... oxaliplatin | 18 Years - 75 Years | Fujian Medical University | |
Study of PEP02, Irinotecan or Docetaxel in Gastric or Gastroesophageal Junction Adenocarcinoma | NCT00813072 | Stomach Neoplas... Esophageal Neop... | PEP02 irinotecan docetaxel | 18 Years - | PharmaEngine | |
Preoperative Dose-dense Chemotherapy With Weekly Cisplatin, Epirubicin and Paclitaxel to Treat Patients With Locally Gastric Cancer | NCT01830270 | Stomach Neoplas... Oesophageal Jun... Lower Oesophagu... | Epirubicin Cisplatin Paclitaxel gastric surgery | 18 Years - 70 Years | Centre Hospitalier Universitaire de Besancon | |
Prophylactic or Preemptive Entecavir in Patients With Gastric Cancer Who Are Inactive Hepatitis B Carriers | NCT02777801 | Stomach Neoplas... | Entecavir | 18 Years - 75 Years | Sun Yat-sen University | |
A Phase 2 Trial of Optimizing Platinum-Based Chemotherapy Based on ERCC1 Expression as First-Line Treatment in Patients With Locally Advanced or Metastatic Gastric Cancer | NCT01967875 | Stomach Neoplas... | Capecitabine+Ci... Docetaxel+Capec... | 18 Years - 65 Years | China Medical University, China | |
Effect of Acupuncture for QoL in Gastric Cancer Patients Undergoing Adjuvant Chemotherapy: a Pilot Study | NCT03753399 | Stomach Neoplas... | acupuncture | 18 Years - 75 Years | Guangzhou University of Traditional Chinese Medicine | |
Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy in Participants Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (MK-3475-859/KEYNOTE-859) | NCT03675737 | Stomach Neoplas... | Pembrolizumab Cisplatin 5-fluorouracil oxaliplatin capecitabine Placebo for Pem... | 18 Years - | Merck Sharp & Dohme LLC | |
Methylation Analysis of Circulating Tumor DNA in Gastric Cancer | NCT04511559 | Stomach Neoplas... Circulating Tum... | Circulating Tum... tissue DNA Meth... | 18 Years - 75 Years | Shanghai Zhongshan Hospital | |
Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer | NCT05297734 | End of Life Cancer | Receive technol... Receive redesig... | 21 Years - | Stanford University | |
Regorafenib in Combination With Paclitaxel in Advanced Oesophagogastric Carcinoma | NCT02406170 | Esophageal Neop... Stomach Neoplas... Neoplasm Metast... | Regorafenib Paclitaxel | 18 Years - | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | |
Efficacy Study of a Low Volume of Water Intake and Mosapride for Endoscopy in Patients With Subtotal Gastrectomy | NCT01284764 | Foreign Body Le... | Mosapride | 18 Years - 80 Years | Inje University | |
The Efficacy of Esomeprazole Premedication on Intraoperative Bleeding During Gastric ESD | NCT02730533 | Stomach Neoplas... | Esomeprazole No PPI treatmen... | 18 Years - | Xijing Hospital of Digestive Diseases | |
Cisplatin and S-1 With or Without Nimotuzumab in Untreated Advanced Gastric Adenocarcinoma | NCT02370849 | Stomach Neoplas... | nimotuzumab cisplatin S-1 | 18 Years - | ChineseAMS | |
Postoperative Analgesic Effect of Subcostal TAPB for Laparoscopic Gastrectomy | NCT04138901 | Postoperative P... | Ultrasound guid... Ropivacaine 0.7... 21G 100 mm stim... | 18 Years - 80 Years | Seoul National University Hospital | |
The Safety and Feasibility of Laparoscopic-assisted Gastrectomy for Advanced Gastric Cancer After Neoadjuvant Chemotherapy | NCT02902575 | Stomach Neoplas... | Laparoscopic-as... | 18 Years - 75 Years | Fujian Medical University | |
A Phase 1/2 Study Evaluating AMG 337 in Asian Subjects | NCT02096666 | Stomach Neoplas... | AMG 337 | 20 Years - | Amgen | |
Effects of Omega-3 Fish Oil Fat Emulsion on Rehabilitation and Immune Function After Radical Surgery Combined With Intraperitoneal Hyperthermic Infusion Chemotherapy in Patients With Locally Advanced Gastric Cancer | NCT06047158 | Fish Oils Perfusion; Comp... Stomach Neoplas... Nutrition Aspec... Chemotherapy Ef... Immunisation Re... | Omega-3 fish oi... | 18 Years - 75 Years | The Affiliated Hospital of Qingdao University | |
Study Evaluating the Efficacy and Safety With CAR-T for Stomach Cancer | NCT02725125 | Stomach Neoplas... | EPCAM-targeted ... | - 75 Years | Sinobioway Cell Therapy Co., Ltd. | |
Endoscopic Submucosal Dissection in Upper Gastrointestinal Canal With HybridKnife | NCT01185483 | Endoscopy, Dige... Esophageal Neop... Stomach Neoplas... | 18 Years - 85 Years | Odense University Hospital | ||
Surgery Plus Intraoperative Peritoneal Hyperthermic Chemotherapy (IPHC) to Treat Peritoneal Carcinomatosis | NCT00454519 | Stomach Neoplas... Colorectal Neop... Neoplasm Metast... Mesothelioma | cytoreductive s... intraoperative ... | 20 Years - 70 Years | Wuhan University | |
Severe Complications After Gastrectomy for Esophagogastric Junction and Gastric Cancer | NCT03909997 | Gastric Cancer Esophagogastric... | 18 Years - | Hospital Dr Sotero del Rio |